Global Endometrial Resection Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Endometrial Resection Devices Market Overview

The Endometrial Resection Devices Market was valued at USD 1.50 billion in 2025 and is projected to reach USD 2.57 billion by 2033, growing at a CAGR of 7.00% from 2026 to 2033. The market is witnessing steady growth driven by the rising prevalence of abnormal uterine bleeding (AUB), increasing preference for minimally invasive gynecological procedures, and continuous technological advancements in hysteroscopic and endometrial ablation systems.

The growing burden of gynecological disorders such as menorrhagia, uterine polyps, and endometrial hyperplasia, coupled with increasing awareness regarding early diagnosis and treatment options, is encouraging hospitals and specialty clinics to adopt advanced resection devices. In addition, the shift toward outpatient and ambulatory surgical procedures, supported by faster recovery times, lower procedural risks, and reduced healthcare costs, is accelerating product adoption globally. Technological innovations including bipolar resection systems, disposable hysteroscopic instruments, and integrated visualization platforms are further improving procedural accuracy, patient safety, and clinical outcomes across both developed and emerging healthcare markets.

Key Market Trends & Insights

• North America dominated the Endometrial Resection Devices Market with the largest revenue share of 38.46% in 2025, supported by advanced gynecological healthcare infrastructure, high adoption of minimally invasive procedures, and favorable reimbursement policies.
• The Radiofrequency Ablation segment led the market with a 39.84% share in 2025, driven by its high procedural efficiency, reduced treatment duration, and increasing adoption in minimally invasive gynecological procedures.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 7.1% from 2026 to 2033, fueled by rising awareness of women’s health, expanding healthcare access, and growing investments in minimally invasive surgical technologies across China, India, and Japan.
• Hysteroscopy Ablation are the fastest-growing technology, projected to register a CAGR of 7.1%, reflecting the surge in demand for direct uterine visualization and precision-guided minimally invasive procedures.
• The Resectoscope segment dominated the device type category with a 36.92% revenue share in 2025, led by its extensive use in hysteroscopic resection procedures and strong adoption across hospitals and specialty gynecology centers.
• Management of Abnormal Uterine Bleeding accounted for 42.67% of the market, preferred by the increasing global prevalence of abnormal menstrual conditions among women across reproductive and peri-menopausal age groups.
• The Endometrial Polyp Removal segment is the fastest-growing application category, with a CAGR of 6.8%, driven by increasing diagnostic screening rates and rising incidence of uterine abnormalities among aging female populations.

Market Size & Forecast

• Global Market Value (2025): USD 1.50 Billion
• Expected Market Value (2033): USD 2.57 Billion
• Forecast CAGR (2026–2033): 7.00%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia Pacific

Report Scope and Endometrial Resection Devices Market Segmentation

Endometrial Resection Devices Market Trends

Trend: Rising Preference for Minimally Invasive Gynecological Procedures

Hospitals and specialty gynecology centers are increasingly adopting minimally invasive endometrial resection devices to improve patient comfort, reduce hospitalization duration, and minimize post-operative complications compared to conventional surgical treatments. The integration of hysteroscopic visualization systems and bipolar energy technologies enables higher procedural precision and safer tissue removal outcomes. Ambulatory surgical centers are similarly utilizing advanced resection systems to expand outpatient treatment capabilities through efficient and cost-effective procedural workflows, while disposable instruments and compact platforms support improved infection prevention and operational flexibility in modern gynecological care settings.

For instance, in March 2024, Olympus Corporation expanded its minimally invasive gynecological endoscopy portfolio with advanced visualization technologies designed to support precision-based hysteroscopic procedures in outpatient and hospital environments.

Endometrial Resection Devices Market Dynamics

Key Market Driver: Increasing Prevalence of Abnormal Uterine Bleeding Disorders

The growing incidence of abnormal uterine bleeding, uterine polyps, and endometrial abnormalities has created substantial demand for advanced endometrial resection devices capable of delivering effective minimally invasive treatment with reduced recovery times and lower procedural risks. Hospitals, specialty clinics, and ambulatory surgical centers are increasingly adopting hysteroscopic resection technologies as a core component of gynecological treatment pathways, improving procedural efficiency, patient outcomes, and healthcare resource utilization. Rising awareness regarding early diagnosis and women’s reproductive health management is further accelerating the adoption of technologically advanced resection systems across both developed and emerging healthcare markets globally.

For instance, in January 2025, Hologic, Inc. announced expanded clinical adoption initiatives for its gynecological surgical technologies focused on improving minimally invasive treatment accessibility for abnormal uterine bleeding management.

Key Restraint/Challenge: High Procedural and Equipment Acquisition Costs

A significant restraint in the Endometrial Resection Devices Market is the high procurement and operational cost associated with advanced hysteroscopic systems, bipolar energy devices, visualization platforms, and disposable surgical instruments used during minimally invasive procedures. Modern endometrial resection platforms require substantial investment in equipment acquisition, physician training, maintenance, and sterilization infrastructure, increasing the total cost burden for healthcare providers and smaller specialty clinics. Limited reimbursement support and budget constraints in developing healthcare systems further restrict widespread technology adoption, particularly among cost-sensitive institutions lacking specialized gynecological surgical infrastructure and experienced clinical personnel for advanced procedural implementation.

For instance, in October 2024, Medtronic plc highlighted increasing healthcare provider concerns regarding capital expenditure pressures associated with adopting advanced minimally invasive surgical technologies across emerging hospital networks.

Key Market Opportunity: Expansion of Outpatient and Ambulatory Gynecological Care

The expansion of outpatient and ambulatory gynecological care presents a significant market opportunity. Advanced endometrial resection devices enable shorter procedure durations, faster patient recovery, and reduced hospitalization requirements, making them highly suitable for ambulatory surgical center environments and office-based gynecological treatment settings. The development of compact hysteroscopic systems, disposable instruments, and integrated imaging platforms is further improving accessibility to minimally invasive procedures while supporting infection prevention and workflow efficiency. Rising healthcare infrastructure investments across Asia-Pacific, Latin America, and Middle Eastern countries are In addition creating favorable growth opportunities for manufacturers expanding into underserved women’s healthcare markets globally. For instance, in February 2025, KARL STORZ SE & Co. KG introduced enhanced compact hysteroscopy solutions aimed at supporting outpatient gynecological procedures and expanding minimally invasive women’s healthcare access in emerging regions.

Endometrial Resection Devices Market Scope

The endometrial resection devices market is segmented on the basis of technology, device type, application, and end-use.

• By Technology

On the basis of technology, the Endometrial Resection Devices Market is segmented into radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon, hysteroscopy ablation, and others. The Radiofrequency Ablation segment dominated the market with a 39.84% share in 2025, owing to its high procedural efficiency, reduced treatment duration, and increasing adoption in minimally invasive gynecological procedures. These systems are widely preferred for treating abnormal uterine bleeding due to their precision, controlled tissue destruction, and faster patient recovery times. Hospitals and specialty clinics increasingly utilize radiofrequency technologies because they minimize surgical complications and reduce hospital stays. Continuous advancements in bipolar energy delivery systems and integrated visualization technologies are further improving clinical outcomes. The technology also supports outpatient treatment settings, making procedures more cost-effective for healthcare providers. Its strong clinical acceptance and broad physician familiarity continue to reinforce segment dominance globally.

The Hysteroscopy Ablation segment is projected to register the fastest growth at a CAGR of 7.1% from 2026 to 2033, driven by rising demand for direct uterine visualization and precision-guided minimally invasive procedures. These systems allow gynecologists to accurately identify and remove abnormal endometrial tissue while preserving surrounding healthy structures. Technological advancements in compact hysteroscopic devices, HD imaging systems, and disposable instruments are significantly improving procedural safety and operational efficiency. Increasing adoption in ambulatory surgical centers and office-based gynecology practices is further accelerating market growth. Growing awareness regarding early diagnosis of uterine disorders and expanding women’s healthcare infrastructure are also supporting demand. The segment In addition benefits from rising preference for fertility-preserving and low-recovery-time treatment approaches.

• By Device Type

On the basis of device type, the Endometrial Resection Devices Market is segmented into remote temperature probe, ablation catheter, resectoscope, radiofrequency electrodes, ablation surgical antennas, and laser ablation catheter. The Resectoscope segment led the market with a 36.92% share in 2025, driven by its extensive use in hysteroscopic resection procedures and strong adoption across hospitals and specialty gynecology centers. These devices provide high procedural accuracy and effective removal of abnormal endometrial tissue during minimally invasive surgeries. Physicians widely prefer resectoscopes because they offer superior visualization and controlled tissue excision capabilities. Continuous technological improvements including bipolar resectoscopes and ergonomic device designs are further enhancing surgical performance and patient safety. Increasing prevalence of abnormal uterine bleeding and uterine fibroids is also contributing to higher procedural volumes globally. The segment continues to benefit from established clinical familiarity and widespread integration into gynecological surgical practices.

The Ablation Catheter segment is expected to witness the fastest growth at a CAGR of 6.9% from 2026 to 2033, driven by increasing preference for minimally invasive outpatient procedures and shorter treatment durations. These catheters provide targeted tissue ablation with reduced procedural complexity and faster patient recovery compared to conventional surgical alternatives. Growing adoption of disposable catheter-based systems is improving infection control and operational convenience in healthcare facilities. Technological advancements in flexible catheter designs and energy delivery mechanisms are further strengthening treatment efficiency and procedural precision. Expanding ambulatory surgical center infrastructure and rising awareness regarding minimally invasive gynecological care are accelerating segment adoption. The segment is also benefiting from increasing healthcare investments in emerging markets and growing physician preference for simplified procedural workflows.

• By Application

On the basis of application, the Endometrial Resection Devices Market is segmented into management of abnormal uterine bleeding, removal of uterine fibroids, endometrial polyp removal, menorrhagia treatment, diagnostic procedures, and endometrial tissue resection. The Management of Abnormal Uterine Bleeding segment dominated the market with a 42.67% share in 2025, owing to the increasing global prevalence of abnormal menstrual conditions among women across reproductive and peri-menopausal age groups. Endometrial resection devices are widely utilized as effective minimally invasive alternatives to hysterectomy for managing heavy menstrual bleeding and related disorders. Rising awareness regarding women’s reproductive healthcare and increasing access to gynecological treatment services are significantly supporting procedural demand. Hospitals and specialty clinics increasingly prefer minimally invasive interventions due to reduced complications and faster patient recovery. Technological advancements in hysteroscopic visualization and energy-based tissue removal systems are also improving treatment outcomes. The segment continues to benefit from growing physician preference for uterus-preserving therapeutic procedures.

The Endometrial Polyp Removal segment is projected to register the fastest growth at a CAGR of 6.8% from 2026 to 2033, driven by increasing diagnostic screening rates and rising incidence of uterine abnormalities among aging female populations. Minimally invasive hysteroscopic procedures are increasingly preferred for accurate detection and targeted removal of endometrial polyps with minimal tissue damage. Advancements in imaging technologies and precision-guided surgical systems are significantly improving procedural safety and clinical effectiveness. Growing awareness regarding early diagnosis of gynecological disorders and preventive women’s healthcare is further supporting market expansion. Increasing availability of outpatient treatment facilities and office-based hysteroscopic procedures is also accelerating adoption globally. The segment In addition benefits from rising healthcare expenditure and improving gynecological care infrastructure in emerging economies.

• By End-Use

On the basis of end-use, the Endometrial Resection Devices Market is segmented into ambulatory surgery center, clinic, and hospitals. The Hospitals segment led the market with a 52.84% share in 2025, driven by high patient inflow, availability of advanced surgical infrastructure, and presence of skilled gynecological specialists. Hospitals remain the primary treatment centers for complex endometrial resection procedures requiring integrated imaging systems and specialized operative support. Increasing adoption of minimally invasive gynecological technologies and growing investments in women’s healthcare departments are further supporting segment growth. These facilities also benefit from favorable reimbursement structures and access to technologically advanced surgical equipment. Rising incidence of abnormal uterine bleeding and gynecological disorders continues to increase procedural volumes across hospital settings globally. The segment maintains strong dominance due to comprehensive clinical capabilities and multidisciplinary treatment support.

The Ambulatory Surgery Center segment is expected to witness the fastest growth at a CAGR of 7.0% from 2026 to 2033, driven by increasing preference for outpatient minimally invasive procedures with reduced hospitalization costs and faster recovery periods. These centers offer cost-effective treatment environments and streamlined procedural workflows, making them highly attractive for endometrial resection procedures. Growing advancements in compact surgical systems and disposable instruments are enabling wider adoption across ambulatory care settings. Patients increasingly prefer ambulatory centers due to shorter waiting times, lower infection risks, and improved convenience. Expanding healthcare infrastructure investments and favorable government initiatives supporting outpatient care models are also accelerating growth. The segment is In addition benefiting from rising physician migration toward specialized minimally invasive gynecological practice centers.

Endometrial Resection Devices Market Regional Analysis

North America dominated the Endometrial Resection Devices Market with the largest revenue share of 38.46% in 2025, supported by advanced gynecological healthcare infrastructure, high adoption of minimally invasive procedures, and favorable reimbursement policies. The region also benefits from favorable reimbursement policies, high awareness regarding women’s reproductive health, and growing utilization of hysteroscopic and endometrial ablation procedures across hospitals and specialty clinics. Increasing focus on outpatient gynecological care and continuous technological advancements in visualization and energy-based surgical systems continue to strengthen North America’s leadership position in the global market.

U.S. Endometrial Resection Devices Market Insight

The U.S. endometrial resection devices market is witnessing strong growth due to rising prevalence of abnormal uterine bleeding, increasing adoption of minimally invasive gynecological procedures, and growing investments in advanced women’s healthcare technologies. The country’s well-established healthcare infrastructure, along with increasing utilization of hysteroscopic and bipolar resection systems, is driving demand across hospitals, specialty clinics, and ambulatory surgical centers. In addition, growing awareness regarding early diagnosis of gynecological disorders and increasing preference for outpatient treatment procedures is accelerating adoption of endometrial resection devices across healthcare facilities and surgical providers.

Europe Endometrial Resection Devices Market Insight

The Europe endometrial resection devices market remains a major contributor to global revenue, driven by strong healthcare infrastructure, technological innovation, and high demand for minimally invasive gynecological treatment solutions. The widespread use of hysteroscopic visualization systems and advanced resection technologies in hospitals and specialty women’s healthcare centers is supporting market expansion across the region. Increasing investments in outpatient surgical care, coupled with favorable reimbursement frameworks and rising awareness regarding reproductive health management, continue to enhance the adoption of endometrial resection devices throughout Europe.

U.K. Endometrial Resection Devices Market Insight

The U.K. endometrial resection devices market is experiencing steady growth, supported by rising adoption of minimally invasive gynecological procedures, increasing investments in women’s healthcare services, and growing demand for cost-effective outpatient treatment solutions. Increasing utilization of hysteroscopic resection systems and disposable surgical instruments is contributing to market growth across hospitals and ambulatory surgical centers. Furthermore, integration of advanced imaging technologies and precision-guided surgical systems is improving procedural efficiency and patient outcomes, positioning the U.K. as a key innovation hub in the endometrial resection devices industry.

Germany Endometrial Resection Devices Market Insight

The Germany endometrial resection devices market is expanding steadily due to the country’s advanced healthcare infrastructure, strong medical technology sector, and increasing adoption of next-generation minimally invasive surgical systems. Hospitals, specialty clinics, and gynecological treatment centers are increasingly utilizing advanced hysteroscopic devices for diagnosis, tissue resection, and therapeutic procedures. Continuous advancements in visualization technologies, bipolar energy systems, and disposable surgical instruments, along with strong government focus on healthcare quality and patient safety, are further driving market growth in Germany.

Asia-Pacific Endometrial Resection Devices Market Insight

The Asia-Pacific endometrial resection devices market is expected to witness rapid growth, driven by increasing healthcare investments, expanding access to gynecological care, and rising awareness regarding women’s reproductive health across countries such as China, India, and Japan. Growing prevalence of abnormal uterine bleeding disorders, rising adoption of minimally invasive surgical technologies, and increasing demand for affordable outpatient treatment solutions are supporting regional market expansion. In addition, the growing presence of private healthcare providers and improving healthcare infrastructure is accelerating endometrial resection device adoption across hospitals and specialty clinics.

Japan Endometrial Resection Devices Market Insight

The Japan endometrial resection devices market is witnessing consistent growth due to rising investments in advanced gynecological treatment technologies, increasing awareness regarding minimally invasive procedures, and strong focus on women’s healthcare initiatives. Healthcare providers, specialty clinics, and research hospitals are increasingly adopting hysteroscopic resection systems for precision-based diagnosis and treatment procedures. Moreover, increasing integration of advanced imaging systems and Japan’s focus on high-quality, patient-centered healthcare solutions are further contributing to market growth.

China Endometrial Resection Devices Market Insight

The China endometrial resection devices market is growing rapidly, driven by increasing healthcare modernization, expanding hospital infrastructure, and rising government focus on women’s reproductive healthcare services. Growing adoption of minimally invasive hysteroscopic technologies across hospitals, specialty clinics, and ambulatory surgical centers is significantly boosting market demand. In addition, rising investments in medical technology development, increasing awareness regarding gynecological disorder management, and rapid healthcare infrastructure expansion are positioning China as one of the fastest-growing markets for endometrial resection devices globally.

Endometrial Resection Devices Market Share

The endometrial resection devices industry is primarily led by well-established companies, including:

• Hologic, Inc. (U.S.)
• Olympus Corporation (Japan)
• KARL STORZ SE & Co. KG (Germany)
• Medtronic (Ireland)
• Boston Scientific Corporation (U.S.)
• CooperSurgical, Inc. (U.S.)
• Richard Wolf GmbH (Germany)
• Stryker (U.S.)
• Braun SE (Germany)
• Johnson & Johnson Services, Inc. (U.S.)
• Cook Medical LLC (U.S.)
• CONMED Corporation (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• PENTAX Medical (Japan)
• SCHÖLLY FIBEROPTIC GMBH (Germany)
• Ackermann Instrumente GmbH (Germany)
• Delmont imaging (France)
• Lina Medical ApS (Denmark)
• Maxer Endoscopy GmbH (Germany)
• XION GmbH (Germany)

Latest Developments in Endometrial Resection Devices Market

• In January 2025, Hologic, Inc. expanded the commercial rollout of its Fluent® Pro Fluid Management System designed for hysteroscopic procedures and endometrial tissue resection applications. The system introduced enhanced suction control, SmartFlo™ pressure optimization technology, and improved visualization capabilities to support faster and more efficient minimally invasive gynecological procedures. The development reflects growing industry focus on improving outpatient hysteroscopy workflows and procedural precision in women’s healthcare
• In October 2024, Olympus Corporation strengthened its gynecological endoscopy portfolio by advancing minimally invasive hysteroscopy technologies aimed at improving visualization and precision during endometrial resection and uterine tissue removal procedures. The company emphasized enhanced imaging performance and physician workflow efficiency to support rising demand for minimally invasive gynecological surgeries globally
• In February 2023, KARL STORZ SE & Co. KG introduced upgraded hysteroscopic instrumentation and visualization systems for minimally invasive gynecological procedures, including endometrial resection and intrauterine tissue management. The launch focused on improving procedural accuracy, ergonomic handling, and integrated imaging performance for hospitals and ambulatory surgical centers. The development highlighted the growing adoption of advanced hysteroscopy platforms in women’s healthcare practices
• In January 2021, Hologic, Inc. announced the European launch of its Fluent® Fluid Management System for hysteroscopic procedures, designed to simplify and streamline fluid management during minimally invasive gynecological surgeries. The system incorporated integrated MyoSure® tissue removal compatibility, advanced pressure control, and workflow optimization technologies to improve procedural efficiency and clinical confidence for healthcare professionals performing endometrial tissue resection procedures
• In April 2021, Medtronic plc continued expanding its minimally invasive women’s health surgical technology initiatives through advanced energy-based surgical platforms supporting gynecological tissue management and hysteroscopic procedures. The company focused on improving procedural safety, precision, and efficiency for hospitals and specialty gynecology centers performing minimally invasive uterine and endometrial treatment interventions globally

SKU-55899